RT Journal Article
SR Electronic
T1 SARS-CoV-2: Viral Mechanisms and Possible Therapeutic Targets – What to learn from Rheumatologists?
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP jrheum.200657
DO 10.3899/jrheum.200657
A1 Carlos Antonio  Mouraa
A1 Ana Luísa Cerqueira de Sant’Ana Costa
YR 2020
UL http://www.jrheum.org/content/early/2020/05/20/jrheum.200657.abstract
AB It was with great interest that we read the letter from Randy Cron and collaborators (1) linking the cytokine storm syndrome (CSS) seen in macrophage activation syndrome, common in the rheumatological setting, with the CSS postulated to be a background in the novel coronavirus (SARS-CoV-2) infection. Amid the high contagiousness of the virus, science was also infected by an infodemia, compelled to enter a race to find effective therapies studying mechanisms molecular aspects of SARS-CoV-2 concomitant to urgent bedside manage of patients.